| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Minimal Physiologically Based Pharmacokinetic Model with a Nested Endosome Compartment for Novel Engineered Antibodies
|
Yuan, Dongfen
|
|
2018
|
20 |
3 |
p. 1-11
|
article
|
| 2 |
A Simple Approach to Determine a Curve Fitting Model with a Correct Weighting Function for Calibration Curves in Quantitative Ligand Binding Assays
|
Xiang, Yuhong
|
|
2018
|
20 |
3 |
p. 1-9
|
article
|
| 3 |
Comparison of Model Averaging and Model Selection in Dose Finding Trials Analyzed by Nonlinear Mixed Effect Models
|
Buatois, Simon
|
|
2018
|
20 |
3 |
p. 1-9
|
article
|
| 4 |
Computational Fragment-Based Drug Design: Current Trends, Strategies, and Applications
|
Bian, Yuemin
|
|
2018
|
20 |
3 |
p. 1-11
|
article
|
| 5 |
Correction to: Model-Based Adaptive Optimal Design (MBAOD) Improves Combination Dose Finding Designs: an Example in Oncology
|
Pierrillas, Philippe B.
|
|
2018
|
20 |
3 |
p. 1
|
article
|
| 6 |
Deep Learning for Drug Design: an Artificial Intelligence Paradigm for Drug Discovery in the Big Data Era
|
Jing, Yankang
|
|
2018
|
20 |
3 |
p. 1-10
|
article
|
| 7 |
Detection of Memory B Activity Against a Therapeutic Protein in Treatment-Naïve Subjects
|
Liao, Karen
|
|
2018
|
20 |
3 |
p. 1-11
|
article
|
| 8 |
Development of Fc-Fused Cocaine Hydrolase for Cocaine Addiction Treatment: Catalytic and Pharmacokinetic Properties
|
Chen, Xiabin
|
|
2018
|
20 |
3 |
p. 1-7
|
article
|
| 9 |
Dissolution and Translational Modeling Strategies Enabling Patient-Centric Drug Product Development: the M-CERSI Workshop Summary Report
|
Abend, Andreas
|
|
2018
|
20 |
3 |
p. 1-8
|
article
|
| 10 |
Equivalence Testing of Complex Particle Size Distribution Profiles Based on Earth Mover’s Distance
|
Hu, Meng
|
|
2018
|
20 |
3 |
p. 1-10
|
article
|
| 11 |
Equivalence Testing of Complex Particle Size Distribution Profiles Based on Earth Mover’s Distance
|
Hu, Meng
|
|
|
20 |
3 |
|
article
|
| 12 |
Evaluation of 4β-Hydroxycholesterol and 25-Hydroxycholesterol as Endogenous Biomarkers of CYP3A4: Study with CYP3A-Humanized Mice
|
Nitta, Shin-ichiro
|
|
2018
|
20 |
3 |
p. 1-9
|
article
|
| 13 |
Feasibility of Exposure-Response Analyses for Clinical Dose-Ranging Studies of Drug Combinations
|
Papathanasiou, Theodoros
|
|
2018
|
20 |
3 |
p. 1-13
|
article
|
| 14 |
Generic Anti-PEG Antibody Assay on ProterixBio’s (Formerly BioScale) ViBE Platform Shows Poor Reproducibility
|
Chilewski, Shannon D.
|
|
2018
|
20 |
3 |
p. 1-5
|
article
|
| 15 |
Improved Prediction of Blood–Brain Barrier Permeability Through Machine Learning with Combined Use of Molecular Property-Based Descriptors and Fingerprints
|
Yuan, Yaxia
|
|
2018
|
20 |
3 |
p. 1-10
|
article
|
| 16 |
Investigation of the Mechanism of Therapeutic Protein-Drug Interaction Between Methotrexate and Golimumab, an Anti-TNFα Monoclonal Antibody
|
Wang, Weirong
|
|
2018
|
20 |
3 |
p. 1-10
|
article
|
| 17 |
Measuring the Impact of Gastrointestinal Variables on the Systemic Outcome of Two Suspensions of Posaconazole by a PBPK Model
|
Hens, Bart
|
|
2018
|
20 |
3 |
p. 1-14
|
article
|
| 18 |
PharmTeX: a LaTeX-Based Open-Source Platform for Automated Reporting Workflow
|
Rasmussen, Christian Hove
|
|
2018
|
20 |
3 |
p. 1-11
|
article
|
| 19 |
Selection of a Ligand-Binding Neutralizing Antibody Assay for Benralizumab: Comparison with an Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) Cell-Based Assay
|
Wu, Yuling
|
|
2018
|
20 |
3 |
p. 1-11
|
article
|
| 20 |
Therapeutic Potential of Engineered Extracellular Vesicles
|
Mentkowski, Kyle I.
|
|
2018
|
20 |
3 |
p. 1-17
|
article
|
| 21 |
Towards Bridging Translational Gap in Cardiotoxicity Prediction: an Application of Progressive Cardiac Risk Assessment Strategy in TdP Risk Assessment of Moxifloxacin
|
Patel, Nikunjkumar
|
|
2018
|
20 |
3 |
p. 1-13
|
article
|
| 22 |
Why Drugs Fail in Late Stages of Development: Case Study Analyses from the Last Decade and Recommendations
|
Parasrampuria, Dolly A.
|
|
2018
|
20 |
3 |
p. 1-16
|
article
|
Journal description